Drug Development


Shares of oncology-focused biopharmaceutical company Arcus Biosciences, Inc. (RCUS) are trading 15 percent higher on Thursday. The company on Wednesday reported positive clinical activity from its three-arm randomized Phase 2 ARC-7 study. The company said that the first interim analysis of the three-arm...

Eli Lilly and Company (LLY) announced positive results from the late-stage study of its drug candidate mirikizumab in ulcerative colitis (UC).

Gilead Sciences, Inc. (GILD) and Merck (MRK) announced that they have entered into a deal to jointly develop and commercialize long-acting treatments in HIV.

fdaaprovedim sep19 22jan21 Thursday, the U.S. Food and Drug Administration approved first extended-release, injectable drug regimen for the treatment of HIV infection in adults.

nobelprizeformedicine oct05 This year's Nobel Prize in Medicine is awarded jointly to to three scientists for the discovery of Hepatitis C virus, a landmark achievement in the ongoing battle against viral diseases. Harvey J. Alter, Michael Houghton and Charles M. Rice made a decisive contribution to the fight against blood-borne hepatitis, a major global health problem that causes cirrhosis and liver cancer in people aroun

Follow RTT